Greenberg Cancer Discovery blog post imageMany families are acutely aware that BRCA1 and BRCA2 are the most important breast and ovarian cancer susceptibility genes. But recently a team including researchers at Penn Medicine discovered another risk it can pose in cancer patients when both parents carry the mutation. Read more
Before we ring in the New Year, the Penn Medicine department of Communications is taking a look back at 2014, a year filled with more breakthroughs in medical research, growth at the Penn Medicine campus, and philanthropic support. This year, we took a different approach and put together a year...
With such astounding shortfalls in funding for biomedical research, Penn Medicine, a key stakeholder of the new Penn Center for Innovation (PCI), is looking for fresh ways to fund research and partner with the private sector. The PCI consolidates and unifies the enterprise previously known as the Penn Center for Technology Transfer with other campus entities charged with commercializing Penn research and Development into license agreements, sponsored research agreements, startup companies and other collaborative relationships. Read more
Acute myeloid leukemia (AML) is one of those cancers so genetically complex, with its many chromosomal abnormalities and mutations, that it has been hard for doctors to find clinically meaningful information to sort out this diversity. So when three gene sequencing studies from Penn Medicine show patterns that may help... Read more
Perelman School genetics professor Maja Bucan, PhD, told me of her deep appreciation for the work going on at the clinic: “From my first visit to the clinic [Clinic for Special Children], I knew I wanted to be part of their team as a collaborator.” Read more
Late last month Penn Med observed Medical Laboratory Professionals Week, a time to celebrate the hard work and dedication of the 600-plus lab professionals in more than 30 laboratories across the health system.
The first annual Million Dollar Bike Ride is finally here. On Saturday, May 3, 2014, close to 500 riders and many other volunteers and family members will gather at Highline Park on Penn’s campus to raise funds for and awareness about rare diseases. Read more
The new Penn Center for Wound Healing and Reconstruction – to treat people dealing with unrelenting wounds – aims to simplify the process by bringing a cadre of specialists together, centering around patient needs.
Rare Disease Day is an annual event to raise awareness with the general public and decision-makers about rare diseases and their impact on patients’ lives. Read more
Since the official launch of the Affordable Care Act in late 2013, millions of previously uninsured or underinsured Americans have selected plans affording them better access to health care. With all the controversy around the new legislation and questions surrounding the launch of the enrollment web site, little attention was... Read more
With 2014 just around the corner, the Penn Medicine Department of Communications is taking a look back at the many highlights and achievements of our faculty, staff, and students in 2013. From landmark breakthroughs in medical research to system-wide growth, moving forward with new leadership to celebrating milestone accomplishments in...
With this zoomed-in view, the Abramson Family Cancer Research Institute (AFCRI) lab of Celeste Simon, PhD, and postdoctoral fellow, T.S. Karin Eisinger-Mathason PhD, report in Cancer Discovery about the potential of the collagen-modifying enzyme PLOD2 as a new therapeutic target for the treatment of metastatic undifferentiated pleomorphic sarcoma. Read more
Converging lines of evidence just go to show that there are many types of cancer associated with chromosomal translocations, and likely more to be found. Read more
In an online video series, Florie Charles, a doctoral student at the University of California at San Francisco, and founder of Youreka Science, simply uses a white board and colored markers (and occasionally a small cut out mouse -- animal, not computer peripheral) to explain findings from recent papers in an accessible, fresh, and engaging way. One of her newest videos happens to feature a recent publication from the lab of Garret FitzGerald, MD, FRS, director of Penn Medicine's Institute of Translational Medicine and Therapeutics. Read more
To show its gratitude to all laboratory professionals, the department of Pathology and Laboratory Medicine celebrated Medical Laboratory Professionals Week April 22-26, with a host of activities, such as Phillies Night, in appreciation of all the hard work and dedication of the hundreds of staff and faculty members working in more than 30 different laboratories across the Penn campus. Read more
Center for Brain Injury and Repair Presence at Philadelphia Science Festival Reaches Science Enthusiasts of all AgesBy Karen Kreeger | April 22, 2013 | Comments
This year the Center for Brain Injury and Repair is reaching audiences of all stripes at the Philadelphia Science Festival, with their message of how to mind your brain from concussions with hand-on demos. Read more
In early April, Penn Medicine hosted a fast-paced lightning round of presentations highlighting new and emerging technology being used inside and outside the Health System that may help patients and medical professionals alike. “Connected health” is about continuous sensing and monitoring to enable early detection, diagnosis and intervention, and improving outcomes at lower cost. Alternating between internal and external projects, the presenters brought their best ideas and applications to share, explaining how these new devices fit within the existing health care system and, in some cases, how they stretch the boundaries and may change the way healthcare is delivered. Read more
Penn’s signature event at the 3rd annual Philadelphia Science Festival next week is a sure sign of the times. “Big Ideas: Funding and Innovation” draws on current themes and reminders of where the bright ideas really come from.
“We Found a Change In Your DNA And We Don’t Know What it Means” – Questions and Challenges in the Era of Massively Parallel Gene SequencingBy Holly Auer | April 15, 2013 | Comments
Women who develop breast cancer while they’re young are often searching for answers about the cause for their disease or what they can do to improve their chances of being cured. While an increasing number of large genetic testing panels promise to scrutinize their DNA to uncover clues, a team of researchers from the Perelman School of Medicine and the Abramson Cancer Center has found that those powerful tests tend to produce more questions than they answer. Read more
Penn Medicine will play a starring role in the Philadelphia Science Festival again this year. The Festival is a citywide collaboration showcasing science and technology every April. This year it runs from April 19 - 28, 10 days to celebrate the region’s strengths in science and technology, bringing together more than 100 partners from academia to museums to restaurants. Read more